Why is Anuh Pharma falling/rising?

As of 01-Sep, Anuh Pharma Ltd's stock price is currently at Rs 87.00, reflecting an increase of Rs 1.0 or 1.16%. Today, the stock has shown a trend reversal, gaining after six consecutive days of decline, and it outperformed its sector by 1.19%. Despite this positive movement, the stock has underperformed in the longer term, with a 1-month return of -9.05% and a year-to-date return of -22.92%. The stock is trading below its moving averages, indicating a bearish trend, and there has been a significant drop in investor participation, with delivery volume decreasing by 48.74% compared to the 5-day average. Additionally, while the company has a low debt-to-equity ratio and an attractive valuation, its profits have fallen by 20.2% over the past year, contributing to the stock's recent struggles.
In the broader market context, Anuh Pharma's short-term performance has been weaker than the benchmark Sensex, which has declined by only 0.29% over the past month. The stock's performance over the past year shows a return of -13.43%, while the Sensex has experienced a minor decline of 2.43%. This stark contrast highlights the challenges faced by Anuh Pharma, particularly in light of poor long-term growth prospects and negative financial results, such as a significant drop in profit after tax and the lowest dividend per share recorded. These factors collectively suggest that while there may be short-term gains, the long-term outlook remains concerning for investors.